Abstract- LPS-Responsive Beige-like Anchor (LRBA) deficiency is a disease which has recently been described in a group of patients with common variable immunodeficiency (CVID) in association with autoimmunity and/or inflammatory bowel disease (IBD)-like phenotype. We here describe a 10-year-old boy who experienced recurrent infections, mainly in the respiratory system, associated with thrombocytopenia and anemia. Immunological workup showed low numbers of B cells and low IgG, but normal IgM levels. In spite of therapeutic doses of antibiotics, antivirals, and antifungal agents, in addition to immunoglobulin replacement therapy, he developed disseminated involvement of both lungs with peripheral nodules; transbronchial lung biopsy revealed possible bronchiolitis obliterans organizing pneumonia (BOOP). Combined homozygosity mapping and exome sequencing identified a homozygous LRBA mutation in this patient (p.Asp248Glufs*2). Such clinical and immunological findings have not been described to date and illustrate the broad and variable clinical phenotype of human LRBA deficiency.
© 2016 Tehran University of Medical Sciences. All rights reserved.
Acta Med Iran, 2016;54(10):620-623.
Keywords: Hypogammaglobulinemia; LRBA deficiency; Hyper IgM; Bronchiolitis obliterans organizing pneumonia
Introduction
Lipopolysaccharide responsive beige-like anchor (LRBA) is an essential gene for the normal function of the immune system. Mutations of the LRBA gene have recently been reported in common variable immunodeficiency (CVID) and autoimmunity (1,2). It seems that inflammatory bowel disease (IBD)-like phenotype in addition to hypogammaglobulinemia and autoimmunity are the main features of patients with LRBA deficiency (1-3).
Interstitial lung diseases (ILD) represent one of the most important late-onset complications of immunodeficient patients, which are rarely seen in children (4). Bronchiolitis obliterans organizing pneumonia (BOOP) is a clinicopathologic syndrome, clinically apparent by sub-acute or chronic dry cough and shortness of breath. BOOP is characterized histopathologically by the presence of granulation tissue in the bronchiolar lumen, alveolar ducts, and some alveoli, associated with variable degrees of interstitial and airspace infiltration by mononuclear cells and foamy macrophages (5).
Materials and Methods
Herein, a 10-year-old Persian boy is presented who was referred to our center with recurrent infections and autoimmunity. His parents are cousins and healthy. He has a 5-year-old healthy sister, and there is no history of sibling death in the family. His uncle has died because of hematologic malignancy. He was 2 when he came with a history of an episode of severe upper respiratory infection and gastroenteritis leading to hospitalization at 2 years of age. Severe disseminated varicella infection occurred 8 months later and soon afterward he developed thrombocytopenia and splenomegaly and had received intravenous immunoglobulin (IVIG) therapy with an initial diagnosis of Immune Thrombocytopenic Purpura (ITP) after bone marrow smears did not show any pathology. He experienced chronic and recurrent oral thrush and multiple episodes of acute immune hemolytic anemia with warm autoantibodies, positive coombs test, while the repeat bone marrow aspiration at four years of age was normal. Frequent otitis media and mastoiditis led to mastoidectomy of the patient, while unilateral sensory-neural hearing loss and facial nerve palsy remained as a consequence of contagious infection of the ear or another autoimmune process.
When he was 7-year-old, he developed a brain abscess, but no microorganism was detected. Severe respiratory involvement included a productive cough, exertional dyspnea, and shortness of breath and cyanosis with the progressive course and became obvious after the age of 8 years.
Results
Immunological workup was compatible with an immunodeficiency with decreased IgG and IgA, but normal IgM phenotype, and a low number of B cells (Table 1).
Serologic studies for EBV and CMV was negative at that time (IgG and IgM). Accordingly, monthly IVIG substitution was commenced. Despite regular IVIG treatment, the pulmonary condition worsened and computed tomography (CT) scan revealed diffuse nodular involvement in peripheral areas of both lungs. Bronchoalveolar lavage showed concomitant colonization with Pseudomonas aeruginosin, Pneumocystis jirovecii and CMV (positive on PCR). Despite therapeutic doses of antibiotics, antivirals, and antifungal agents, the respiratory signs and symptoms progressed, and CT scan revealed the disseminated involvement of both lungs with peripheral nodules (Figure 1).
Transbronchial lung biopsy was performed and showed lung tissue infiltration by severe inflammatory cells including lymphocytes, PMN leukocytes, few plasma cells and numerous macrophages, PAS and Ziehl-Neelsen staining shows no fungal or acid fast bacilli respectively. In some area, the histology is reminiscent to beginning a phase of bronchiolitis obliterans with organizing pneumonia (BOOP), which is a form of interstitial lung disease (Figure 2).
Pulmonary symptoms improved markedly after treatment with systemic corticosteroids, but no imaging of lungs has been performed after therapy. Simultaneously, blood PCR for EBV, CMV, HSV and adenovirus were studied which were all negative.
CD40LG gene was sequenced, which was intact. Combined homozygosity mapping and exome sequencing confirmed a homozygous, severe mutation in the LRBA gene, leading to frameshift insertion (NM_001199282:c.743_744insAAGA:p.Asp248Glufs* 2) (6). Both parents were heterozygous carriers of the mutation, in line with the known autosomal recessive mode of inheritance.
Discussion
According to previous reports, LRBA deficiency usually presents with a variety of manifestations, including hypogammaglobulinemia, accompanied by autoimmune disorders and/or IBD-like phenotype (710). However, this case has a low level of IgG in association with normal IgM level. Moreover, a low number of B cells resembled an autosomal or X-linked agammaglobulinemia with low B cell number. However, Next Generation Sequencing (NGS) confirmed the diagnosis of LRBA deficiency in this case. In addition, BOOP is one of the rarest pulmonary complications of primary immunodeficiency diseases (PIDs) in children, as it is usually among the late onset complications. The occurrence of such immunodeficiency phenotype due to LRBA mutation and occurrence of BOOP in childhood as a complication of primary immunodeficiency has not been reported yet, especially in children. Meanwhile, mutations in this gene could also lead to a variety of immunodeficiencies, ranging from an immunoglobulin deficiency to low a number of B cells.
References
1. Lopez-Herrera G, Tampella G, Pan-Hammarström Q, Herholz P, Trujillo-Vargas CM, Phadwal K, Simon AK, et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 2012;90:986-1001.
2. Alangari A, Alsultan A, Adly N, Massaad MJ, Kiani IS, Aljebreen A, et al. LPS-responsive beige-like anchor (LRBA) gene mutation in a family with inflammatory bowel disease and combined immunodeficiency. J Allergy Clin Immunol 2012;130:481-8.e2.
3. Serwas NK, Kansu A, Santos-Valente E, Kuloglu Z, Demir A, Yaman A, et al. Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype. Inflamm Bowel Dis 2015;21:40-7.
4. Jesenak M, Banovcin P, Jesenakova B, Babusikova E. Pulmonary manifestations of primary immunodeficiency disorders in children. Front Pediatr 2014;2:77.
5. Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN. Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review. Ann Thorac Med 2008;3:67-75.
6. Gámez-Díaz L, August D, Stepensky P, Revel-Vilk S, Seidel MG, Noriko M, et al. The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency. J Allergy Clin Immunol. 2016;137:223-30.
7. Burns SO, Zenner HL, Plagnol V, Curtis J, Mok K, Eisenhut M, et al. LRBA gene deletion in a patient presenting with autoimmunity without hypogammaglobulinemia. J Allergy Clin Immunol 2012;130:1428-32.
8. Alkhairy OK, Abolhassani H, Rezaei N, Fang M, Andersen KK, Chavoshzadeh Z, et al. Spectrum of Phenotypes Associated with Mutations in LRBA. J Clin Immunol 2016;36:33-45.
9. Serwas NK, Kansu A, Santos-Valente E, Kuloglu Z, Demir A, Yaman A, et al. Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype. Inflam Bowel Dis 2015;21:40-7.
10. Charbonnier LM, Janssen E, Chou J, Ohsumi TK, Keles S, Hsu JT, et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, Xlinked-like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol 2015;135:217-27.
Sima Shokri1, Mohammad Nabavi1, Tatjana Hirschmugl2, Asghar Aghamohammadi3, Saba Arshi1, Mohamad Hassan Bemanian1, Morteza Fallahpour1, Rasool Molatefi1, Mahsa Rekabi1, Narges Eslami1, Javad Ahmadian1, Kian Darabi1, Gholam Reza Sedighi1, Maryam Monajemzadeh5, Mohammadreza Modaresi5,6, Nima Parvaneh3, Kaan Boztug2,7, and Nima Rezaei3,4,8
1 Department of Allergy and Clinical Immunology, Rasool-e-Akram Hospital, Iran University of Medical Sciences, Tehran, Iran
2 CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, Vienna, Austria
3 Research Center for Immunodeficiencies, Children's Medical Center, Tehran University ofMedical Sciences, Tehran, Iran
4 Department of Immunology, School of Medicine, Tehran University ofMedical Sciences, Tehran, Iran
5 Pediatrics Center for Excellence, Children's Medical Center, Tehran University ofMedical Sciences, Tehran, Iran
6 Pediatric Respiratory Diseases Education and Research Network (PRDERN), Universal Scientific Education and Research
Network (USERN), Tehran, Iran
7 Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria
8 Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research
Network (USERN), Boston, MA, USA
Received: 01 Aug. 2015; Revised: 12 Sep. 2015, Accepted: 05 Mar. 2016
Corresponding Author: N. Rezaei
Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran
Tel: +98 21 66929234, Fax: +98 21 66929235, E-mail address: [email protected]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Copyright Tehran University of Medical Sciences Publications 2016